Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 08, 2017 16:01 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Present at Upcoming Investor Conference

WALTHAM, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that management will participate in the Jefferies 2017 London Healthcare Conference on...
November 08, 2017 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Announces Autologous Cord Blood Cells Improve Motor Function in Some Children with Cerebral Palsy

WALTHAM, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cord Blood Registry (CBR) from AMAG Pharmaceuticals (Nasdaq:AMAG) today announced research recently published in the journal Stem Cells...
November 06, 2017 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

Hypophosphatemia Data From AMAG Phase 3 Trial Presented at the American Society of Nephrology

Data Shows Patients Treated with Feraheme® (ferumoxytol) were Less Likely to Develop Severe Hypophosphatemia Compared to Those Treated with a Comparator IV Iron WALTHAM, Mass., Nov. 06, 2017 (GLOBE...
November 02, 2017 07:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Highlights

Intrarosa® (prasterone) launch progressing well with nearly 2,000 prescribing physicians in the first 100 days since launch Conference call scheduled for 8:00 a.m. ET today WALTHAM, Mass., Nov. 02,...
October 19, 2017 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Host Third Quarter 2017 Financial Results Conference Call and Webcast on Thursday, November 2, 2017 at 8:00 a.m. ET

WALTHAM, Mass., Oct. 19, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that its third quarter 2017 financial results will be released on Thursday, November 2,...
September 29, 2017 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Appoints Tracy Palmer Berns as Chief Compliance Officer

WALTHAM, Mass., Sept. 29, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Tracy Palmer Berns as chief compliance officer effective immediately....
September 07, 2017 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Appoints Laura Williams, M.D. as Senior Vice President of Clinical Development

WALTHAM, Mass., Sept. 07, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Laura Williams, M.D., M.P.H., as senior vice president of clinical...
September 05, 2017 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Present at Upcoming Investor Conferences

WALTHAM, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will participate in the following investor conferences: Morgan...
August 31, 2017 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Announces U.S. FDA Filing Acceptance and Six-Month Review of Feraheme® (ferumoxytol) for the Treatment of All Adult Patients With Iron Deficiency Anemia

WALTHAM, Mass., Aug. 31, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the U.S. Food and Drug Administration (FDA) accepted its submission to broaden the...
August 08, 2017 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Appoints Oscar Sanchez as Vice President of Quality

WALTHAM, Mass., Aug. 08, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Oscar Sanchez as vice president of quality effective immediately. He...